A new study from Duke University School of Medicine is challenging long-standing views on blood sugar regulation — and pointing to a surprising new ally in the fight against type 2 diabetes. Published ...
ROCKVILLE, Md., Oct. 06, 2025 (GLOBE NEWSWIRE) -- MaxCyte, Inc. (MXCT), a leading cell-engineering company providing enabling platform technologies to advance the discovery, development, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results